Multiple Myeloma in a Patient with Birt-Hogg-Dubé Syndrome

Birt-Hogg-Dubé syndrome (BHDS) is an autosomal dominant disease caused by germline folliculin (FLCN) mutations and it is characterized by skin folliculomas, pulmonary cysts, and renal cell carcinomas (RCC). We herein report the first case of a female patient with BHDS who was diagnosed with multiple myeloma. Daratumumab-based treatment was effective, and the patient remained responsive for over three years. Whole-exome sequencing confirmed an FLCN germline mutation and nine somatic mutations, including an MPDZ mutation, which is a component of the tumor-suppressive Hippo-YAP pathway. Considering the reported association between the Hippo-YAP pathway and RCC with BHDS, an MPDZ mutation may contribute to carcinogenesis in patients with BHDS.

Authors

Institutions

Publication Details

Journal
Internal Medicine
Published
2025-03-14
DOI
https://doi.org/10.2169/internalmedicine.4985-24
Citations
3
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
4.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multiple Myeloma in a Patient with Birt-Hogg-Dubé Syndrome

Fumiaki Matsumura, Yumiko Maruyama, Kunio Kawanishi, Kenichi Makishima et al.
3 citations
Internal Medicine
Renal cell carcinoma treatment
4.56
article

Multiple Myeloma in a Patient with Birt-Hogg-Dubé Syndrome

Fumiaki Matsumura, Yumiko Maruyama, Kunio Kawanishi, Kenichi Makishima, Daisuke Matsubara, Ryota Matsuoka, Naoki Kurita, Toshiaki Usui, Kantaro Ishitsuka, Hirayasu Kai, Sakurako Suma, Tatsuhiro Sakamoto, Yasuhito Suehara, Naoshi Obara, Keiichiro Hattori, Kunihiro Yamagata, Joichi Usui, Hidekazu Nishikii, Takayasu Kato, Mamiko Sakata-Yanagimoto
article en
3 citations

Abstract

Birt-Hogg-Dubé syndrome (BHDS) is an autosomal dominant disease caused by germline folliculin (FLCN) mutations and it is characterized by skin folliculomas, pulmonary cysts, and renal cell carcinomas (RCC). We herein report the first case of a female patient with BHDS who was diagnosed with multiple myeloma. Daratumumab-based treatment was effective, and the patient remained responsive for over three years. Whole-exome sequencing confirmed an FLCN germline mutation and nine somatic mutations, including an MPDZ mutation, which is a component of the tumor-suppressive Hippo-YAP pathway. Considering the reported association between the Hippo-YAP pathway and RCC with BHDS, an MPDZ mutation may contribute to carcinogenesis in patients with BHDS.

Internal MedicineVol. 64(18)
SHOWA Medical University (JP), University of Tsukuba (JP), University of Tsukuba Hospital (JP), Ibaraki Prefectural Central Hospital (JP)
Openalex Percentile: Top 6%
Renal cell carcinoma treatment
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.